{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:30:29Z","timestamp":1787002229133,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T00:00:00Z","timestamp":1302134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/hr.2011.35","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T09:52:23Z","timestamp":1302169943000},"page":"817-824","source":"Crossref","is-referenced-by-count":17,"title":["Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats"],"prefix":"10.1038","volume":"34","author":[{"given":"Taishi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Nako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Tokutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokei","family":"Kim-Mitsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,7]]},"reference":[{"key":"BFhr201135_CR1","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"CG Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT . Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355\u20131364.","journal-title":"Circ Res"},{"key":"BFhr201135_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","volume":"51","author":"NJ Brown","year":"2008","unstructured":"Brown NJ . Aldosterone and vascular inflammation. Hypertension 2008; 51: 161\u2013167.","journal-title":"Hypertension"},{"key":"BFhr201135_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1046\/j.1440-1681.2001.03586.x","volume":"28","author":"J Funder","year":"2001","unstructured":"Funder J . Mineralocorticoids and cardiac fibrosis: the decade in review. Clin Exp Pharmacol Physiol 2001; 28: 1002\u20131006.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr201135_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","volume":"47","author":"N Kobayashi","year":"2006","unstructured":"Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, Matsuoka H . Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 2006; 47: 671\u2013679.","journal-title":"Hypertension"},{"key":"BFhr201135_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M . Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 2006; 47: 656\u2013664.","journal-title":"Hypertension"},{"key":"BFhr201135_CR6","doi-asserted-by":"publisher","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA . Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002; 283: H1802\u2013H1810.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201135_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","volume":"47","author":"EL Schiffrin","year":"2006","unstructured":"Schiffrin EL . Effects of aldosterone on the vasculature. Hypertension 2006; 47: 312\u2013318.","journal-title":"Hypertension"},{"key":"BFhr201135_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT . Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Am J Pathol 2002; 161: 1773\u20131781.","journal-title":"Am J Pathol"},{"key":"BFhr201135_CR9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M . Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309\u20131321.","journal-title":"N Engl J Med"},{"key":"BFhr201135_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999; 341: 709\u2013717.","journal-title":"N Engl J Med"},{"key":"BFhr201135_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","volume":"41","author":"WB White","year":"2003","unstructured":"White WB, Duprez D, St Hillaire R, Krause S, Roniker B, Kuse-Hamilton J, Weber MA . Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension 2003; 41: 1021\u20131026.","journal-title":"Hypertension"},{"key":"BFhr201135_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","volume":"41","author":"JM Flack","year":"2003","unstructured":"Flack JM, Oparil S, Pratt JH, Roniker B, Garthwaite S, Kleiman JH, Yang Y, Krause SL, Workman D, Saunders E . Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol 2003; 41: 1148\u20131155.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201135_CR13","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A . Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the value randomised trial. Lancet 2004; 363: 2022\u20132031.","journal-title":"Lancet"},{"key":"BFhr201135_CR14","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","volume":"16","author":"L Liu","year":"1998","unstructured":"Liu L, Wang JG, Gong L, Liu G, Staessen JA . Comparison of active treatment and placebo in older chinese patients with isolated systolic hypertension. Systolic hypertension in china (syst-china) collaborative group. J Hypertens 1998; 16: 1823\u20131829.","journal-title":"J Hypertens"},{"key":"BFhr201135_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","volume":"350","author":"JA Staessen","year":"1997","unstructured":"Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O\u2032Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in europe (syst-eur) trial investigators. Lancet 1997; 350: 757\u2013764.","journal-title":"Lancet"},{"key":"BFhr201135_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/HYPERTENSIONAHA.107.099044","volume":"51","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S . Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension 2008; 51: 296\u2013301.","journal-title":"Hypertension"},{"key":"BFhr201135_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1161\/ATVBAHA.107.153692","volume":"27","author":"E Yamamoto","year":"2007","unstructured":"Yamamoto E, Kataoka K, Shintaku H, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ichijo H, Ogawa H, Kim-Mitsuyama S . Novel mechanism and role of angiotensin ii induced vascular endothelial injury in hypertensive diastolic heart failure. Arterioscler Thromb Vasc Biol 2007; 27: 2569\u20132575.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201135_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/HYPERTENSIONAHA.107.095315","volume":"50","author":"E Yamamoto","year":"2007","unstructured":"Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S . Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat. Hypertension 2007; 50: 657\u2013662.","journal-title":"Hypertension"},{"key":"BFhr201135_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/HYPERTENSIONAHA.109.135392","volume":"54","author":"T Nakamura","year":"2009","unstructured":"Nakamura T, Kataoka K, Fukuda M, Nako H, Tokutomi Y, Dong YF, Ichijo H, Ogawa H, Kim-Mitsuyama S . Critical role of apoptosis signal-regulating kinase 1 in aldosterone\/salt-induced cardiac inflammation and fibrosis. Hypertension 2009; 54: 544\u2013551.","journal-title":"Hypertension"},{"key":"BFhr201135_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00004872-200018010-00016","volume":"18","author":"R Doi","year":"2000","unstructured":"Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M . Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in dahl salt-sensitive rats. J Hypertens 2000; 18: 111\u2013120.","journal-title":"J Hypertens"},{"key":"BFhr201135_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.CIR.103.1.148","volume":"103","author":"S Kim","year":"2001","unstructured":"Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, Iwao H . Effects of combination of ace inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 2001; 103: 148\u2013154.","journal-title":"Circulation"},{"key":"BFhr201135_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","volume":"20","author":"S Johar","year":"2006","unstructured":"Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM . Aldosterone mediates angiotensin ii-induced interstitial cardiac fibrosis via a nox2-containing nadph oxidase. Faseb J 2006; 20: 1546\u20131548.","journal-title":"Faseb J"},{"key":"BFhr201135_CR23","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","volume":"109","author":"S Keidar","year":"2004","unstructured":"Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M . Aldosterone administration to mice stimulates macrophage nadph oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin ii and aldosterone. Circulation 2004; 109: 2213\u20132220.","journal-title":"Circulation"},{"key":"BFhr201135_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","volume":"52","author":"A Di Zhang","year":"2008","unstructured":"Di Zhang A, Cat AN, Soukaseum C, Escoubet B, Cherfa A, Messaoudi S, Delcayre C, Samuel JL, Jaisser F . Cross-talk between mineralocorticoid and angiotensin ii signaling for cardiac remodeling. Hypertension 2008; 52: 1060\u20131067.","journal-title":"Hypertension"},{"key":"BFhr201135_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00109-008-0323-5","volume":"86","author":"CA Lemarie","year":"2008","unstructured":"Lemarie CA, Paradis P, Schiffrin EL . New insights on signaling cascades induced by cross-talk between angiotensin ii and aldosterone. J Mol Med 2008; 86: 673\u2013678.","journal-title":"J Mol Med"},{"key":"BFhr201135_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","volume":"33","author":"V Robert","year":"1999","unstructured":"Robert V, Heymes C, Silvestre JS, Sabri A, Swynghedauw B, Delcayre C . Angiotensin at1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension 1999; 33: 981\u2013986.","journal-title":"Hypertension"},{"key":"BFhr201135_CR27","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1139\/y85-250","volume":"63","author":"EL Schiffrin","year":"1985","unstructured":"Schiffrin EL, Franks DJ, Gutkowska J . Effect of aldosterone on vascular angiotensin ii receptors in the rat. Can J Physiol Pharmacol 1985; 63: 1522\u20131527.","journal-title":"Can J Physiol Pharmacol"},{"key":"BFhr201135_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.HYP.20.1.67","volume":"20","author":"ME Ullian","year":"1992","unstructured":"Ullian ME, Schelling JR, Linas SL . Aldosterone enhances angiotensin ii receptor binding and inositol phosphate responses. Hypertension 1992; 20: 67\u201373.","journal-title":"Hypertension"},{"key":"BFhr201135_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/HYPERTENSIONAHA.109.149062","volume":"55","author":"T Fujita","year":"2010","unstructured":"Fujita T . Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010; 55: 813\u2013818.","journal-title":"Hypertension"},{"key":"BFhr201135_CR30","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T . Modification of mineralocorticoid receptor function by rac1 gtpase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370\u20131376.","journal-title":"Nat Med"},{"key":"BFhr201135_CR31","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","volume":"54","author":"AS Mihailidou","year":"2009","unstructured":"Mihailidou AS, Loan Le TY, Mardini M, Funder JW . Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009; 54: 1306\u20131312.","journal-title":"Hypertension"},{"key":"BFhr201135_CR32","doi-asserted-by":"publisher","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","volume":"290","author":"A Vidal","year":"2006","unstructured":"Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT . Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006; 290: H286\u2013H294.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr201135_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/hr.2010.159","volume":"33","author":"AA Zia","year":"2010","unstructured":"Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT . From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens Res 2010; 33: 1091\u20131101.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:09:25Z","timestamp":1684415365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFhr201135"],"URL":"https:\/\/doi.org\/10.1038\/hr.2011.35","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,7]]}}}